Proteasome activator PA28γ-dependent nuclear retention and degradation of hepatitis C virus core protein

Journal of Virology

Volumn 77, Issue 19, 2003, Pages 10237-10249

  Moriishi, Kohji ^a   Okabayashi, Tamaki ^a   Nakai, Kousuke ^a   Moriya, Kyoji ^b   Koike, Kazuhiko ^b   Murata, Shigeo ^c   Chiba, Tomoki ^c   Tanaka, Keiji ^c   Suzuki, Ryosuke ^d   Suzuki, Tetsuro ^d   Miyamura, Tatsuo ^d   Matsuura, Yoshiharu ^a  

^a OSAKA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASOME ACTIVATOR PA28GAMMA; UNCLASSIFIED DRUG; VIRUS PROTEIN; AUTOANTIGEN; CORE PROTEIN; KI ANTIGEN; NUCLEAR PROTEIN; PROTEASOME;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; FETUS; FLAVIVIRUS; GENE DELETION; GENE OVEREXPRESSION; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; KNOCKOUT GENE; LIVER CARCINOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TRANSPORT; REGULATORY MECHANISM; TRANSGENIC MOUSE; TRANSPORT KINETICS; VIRUS NUCLEOCAPSID; ACTIVE TRANSPORT; ANIMAL; BINDING SITE; CELL NUCLEUS; CHEMISTRY; GENE LIBRARY; METABOLISM; MOUSE; PHYSIOLOGY;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; AUTOANTIGENS; BINDING SITES; CELL NUCLEUS; GENE LIBRARY; HEPACIVIRUS; HUMANS; MICE; MICE, TRANSGENIC; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; VIRAL CORE PROTEINS;

EID: 0141856404     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.19.10237-10249.2003     Document Type: Article

References (69)

1. Ahn, J. Y., N. Tanahashi, K. Akiyama, H. Hisamatsu, C. Noda, K. Tanaka, C. H. Chung, N. Shibmara, P. J. Willy, J. D. Mott, C. A. Slaughtere, and G. N. DeMartino. 1995. Primary structures of two homologous subunits of PA28, a gamma-interferon-inducible protein activator of the 20S proteasome. FEBS Lett. 366:37-42.
2. Aizaki, H., Y. Aoki, T. Harada, K. Ishii, T. Suzuki, S. Nagamori, G. Toda, Y. Matsuura, and T. Miyamura. 1998. Full-length complementary DNA of hepatitis C virus genome from an infectious blood sample. Hepatology 27:621-627.
3. Albertsen, H. M., S. A. Smith, S. Mazoyer, E. Fujimoto, J. Stevens, B. Williams, P. Rodriguez, C. S. Cropp, P. Slijepcevic, M. Carlson, M. Robertson, P. Bradley, E. Lawrence, T. Harrington, Z. Mei Sheng, R. Hoopes, N. Sternberg, A. Brothman, R. Callahan, B. A. J. Ponder, and R. White. 1994. A physical map and candidate genes in the BRCA1 region on chromosome 17q12-21. Nat. Genet. 7:472-479.
4. Almond, J. B., and G. M. Cohen. 2002. The proteasome: a novel target for cancer chemotherapy. Leukemia 16:433-443.
5. Aoyagi, K., C. Ohue, K. Iida, T. Kimura, E. Tanaka, K. Kiyosawa, and S. Yagi. 1999. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J. Clin. Microbiol. 37:1802-1808.
6. Brooks, P., G. Fuertes, R. Z. Murray, S. Bose, E. Knecht, M. C. Rechsteiner, K. B. Hendil, K. Tanaka, J. Dyson, and J. Rivett. 2000. Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem. J. 346:155-161.
7. Bukh, J., R. H. Purcell, and R. H. Miller. 1994. Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc. Natl. Acad. Sci. USA 91:8239-8243.
8. Chang, S. C., J. H. Yen, H. Y. Kang, M. H. Jang, and M. F. Chang. 1994. Nuclear localization signals in the core protein of hepatitis C virus. Biochem. Biophys. Res. Commun. 205:1284-1290.
9. Choo, Q. L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
10. Choo, Q. L., K. H. Richman, J. H. Han, K. Berger, C. Lee, C. Dong, C. Gallegos, D. Coit, R. Medina-Selby, P. J. Barr, A. J. Weiner, D. W. Bradley, G. Kuo, and M. Houghton. 1991. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 88:2451-2455.
11. Duttweiller, H. M. 1996. A highly sensitive and non-lethal beta-galactosidase plate assay for yeast. Trends Genet. 12:340-341.
12. Grakoui, A., D. W. McCourt, C. Wychowski, S. M. Feinstone, and C. M. Rice. 1993. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J. Virol. 67:2832-2843.
13. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
14. Hope, R. G., and J. McLauchlan. 2000. Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein. J. Gen. Virol. 81:1913-1925.
15. Horton, R. M., H. D. Hunt, S. N. Ho, J. K. Pullen, and L. R. Pease. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68.
16. Houghton, M., A. Weiner, J. Han, G. Kuo, and Q. L. Choo. 1991. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14:381-388.
17. Huang, D. C., S. Cory, and A. Strasser. 1997. Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene 14:405-414.
18. Jin, D. Y., H. L. Wang, Y. Zhou, A. C. Chun, K. V. Kibler, Y. D. Hou, H. Kung, and K. T. Jeang. 2000. Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. EMBO J. 19:729-740.
19. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621-663.
20. Kim, C. M., K. Koike, I. Saito, T. Miyamura, and G. Jay. 1991. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317-320.
21. Kiyosawa, K., T. Sodeyama, E. Tanaka, Y. Gibo, K. Yoshizawa, Y. Nakano, S. Furuta, Y. Akahane, K. Nishioka, and R. H. Purcell. 1990. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675.
22. Knowlton, J. R., S. C. Johnston, F. G. Whitby, C. Realini, Z. Zhang, M. Rechsteiner, and C. P. Hill. 1997. Structure of the proteasome activator REGalpha (PA28alpha). Nature 390:639-643.
23. Kohda, K., T. Ishibashi, N. Shimbara, K. Tanaka, Y. Matsuda, and M. Kasahara. 1998. Characterization of the mouse PA28 activator complex gene family: complete organizations of the three member genes and a physical map of the approximately 150-kb region containing the alpha- and beta-subunit genes. J. Immunol. 160:4923-4935.
24. Koike, K., K. Moriya, S. Iino, H. Yotsuyanagi, Y. Endo, T. Miyamura, and K. Kurokawa. 1994. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19:810-819.
25. Koike, K., T. Tsutsumi, H. Fujie, Y. Shintani, and M. Kyoji. 2002. Molecular mechanism of viral hepatocarcinogenesis. Oncology 62(Suppl. 1):29-37.
26. Kuo, G., Q. L. Choo, H. J. Alter, G. L. Gitnick, A. G. Redeker, R. H. Purcell, T. Miyamura, J. L. Dienstag, M. J. Alter, C. E. Stevens, G. E. Tegtmeier, F. Bonino, M. Colombo, W. S. Lee, C. Kuo, K. Berger, F. R. Shuster, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
27. Lemberg, M. K., and B. Martoglio. 2002. Requirements for signal peptide peptidase-catalyzed intramembrane proteolysis. Mol. Cell 10:735-744.
28. Lerat, H., M. Honda, M. R. Beard, K. Loesch, J. Sun, Y. Yang, M. Okuda, R. Gosert, S. Y. Xiao, S. A. Weinman, and S. M. Lemon. 2002. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122:352-365.
29. Liu, Q., C. Tackney, R. A. Bhat, A. M. Prince, and P. Zhang. 1997. Regulated processing of hepatitis C virus core protein is linked to subcellular localization. J. Virol. 71:657-662.
30. Lo, S. Y., F. Masiarz, S. B. Hwang, M. M. Lai, and J. H. Ou. 1995. Differential subcellular localization of hepatitis C virus core gene products. Virology 213:455-461.
31. Lo, S. Y., M. Selby, M. Tong, and J. H. Ou. 1994. Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino acid substitution. Virology 199:124-131.
32. Lo, S. Y., M. J. Selby, and J. H. Ou. 1996. Interaction between hepatitis C virus core protein and El envelope protein. J. Virol. 70:5177-5182.
33. Mamiya, N., and H. J. Worman. 1999. Hepatitis C virus core protein binds to a DEAD box RNA helicase. J. Biol. Chem. 274:15751-15756.
34. Masson, P., O. Andersson, U. M. Petersen, and P. Young, 2001. Identification and characterization of a Drosophila nuclear proteasome regulator. A homolog of human 11 S REGgamma (PA28gamma). J. Biol. Chem. 276:1383-1390.
35. Matsuura, Y., T. Harada, M. Makimura, M. Sato, H. Aizaki, T. Suzuki, and T. Miyamura. 1994. Characterization of HCV structural proteins expressed in various animal cells. Intervirology 37:114-118.
36. McLauchlan, J., M. K. Lemberg, G. Hope, and B. Martoglio, 2002. Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J. 21:3980-3988.
37. Moradpour, D., T. Wakita, K. Tokushige, R. I. Carlson, K. Krawczynski, and J. R. Wands. 1996. Characterization of three novel monoclonal antibodies against hepatitis C virus core protein. J. Med. Virol. 48:234-241.
38. Moriishi, K., D. C. Huang, S. Cory, and J. M. Adams, 1999. Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1. Proc. Natl. Acad. Sci. USA 96:9683-9688.
39. Moriya, K., H. Fujie, Y. Shintani, H, Yotsuyanagi, T. Tsutsumi, K. Ishibashi, Y. Matsuura, S. Kimura, T. Miyamura, and K. Koike. 1998. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4:1065-1067.
40. Moriya, K., H, Fujie, H. Yotsuyanagi, Y. Shintani, T, Tsutsumi, Y. Matsuura, T. Miyamura, S. Kimura, and K. Koike. 1997. Subcellular localization of hepatitis C virus structural proteins in the liver of transgenic mice. Jpn. J. Med. Sci. Biol. 50:169-177.
41. Moriya, K., H. Yotsuyanagi, Y. Shintani, H. Fujie, K. Ishibashi, Y. Matsuura, T. Miyamura, and K. Koike. 1997. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J. Gen. Virol. 78:1527-1531.
42. Murata, S., H. Kawahara, S. Tohma, K. Yamamoto, M. Kasahara, Y. Nabeshima, K. Tanaka, and T. Chiba. 1999. Growth retardation in mice lacking the proteasome activator PA28gamma. J. Biol. Chem. 274:38211-38215.
43. Murray, R. Z., and C. Norbury. 2000. Proteasome inhibitors as anti-cancer agents. Anticancer Drugs 11:407-417.
44. Nikaido, T., K. Shimada, M. Shibata, M. Hata, M. Sakamoto, Y. Takasaki, C. Sato, T. Takahashi, and Y. Nishida. 1990. Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected with sera from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 79:209-214.
45. Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199.
46. Otsuka, M., N. Kato, K. Lan, H. Yoshida, J. Kato, T. Goto, Y. Shiratori, and M. Omata. 2000. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J. Biol. Chem. 275:34122-34130.
47. Paesen, G. C., and P. A. Nuttall. 1996. A tick homologue of the human Ki nuclear autoantigen. Biochim. Biophys. Acta 1309:9-13.
48. Realini, C., C. C. Jensen, Z. Zhang, S. C. Johnston, J. R. Knowlton, C. P. Hill, and M. Rechsteiner. 1997. Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activators. J. Biol. Chem. 272:25483-25492.
49. Rechsteiner, M., C. Realini, and V. Ustrell. 2000. The proteasome activator 11 S REG (PA28) and class I antigen presentation. Biochem. J. 345:1-15.
50. Roehrig, J. T., L. A. Staudinger, A. R. Hunt, J. H. Mathews, and C. D. Blair. 2001. Antibody prophylaxis and therapy for flavivirus encephalitis infections. Ann. N. Y. Acad. Sci. 951:286-297.
51. Saito, I., T. Miyamura, A. Ohbayashi, H. Harada, T. Katayama, S. Kikuchi, Y. Watanabe, S. Koi, M. Onji, Y. Ohta, Q. Choo, M. Houghton, and G. Kuo. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 87:6547-6549.
52. Santolini, E., G. Migliaccio, and N. La Monica. 1994. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J. Virol. 68:3631-3641.
53. Shimoike, T., S. Mimori, H. Tani, Y. Matsuura, and T. Miyamura. 1999. Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation. J. Virol. 73:9718-9725.
54. Shoji, I., T. Suzuki, M. Sato, H. Aizaki, T, Chiba, Y. Matsuura, and T. Miyamura. 1999. Internal processing of hepatitis C virus NS3 protein. Virology 254:315-323.
55. Suzuki, R., Y. Matsuura, T, Suzuki, A. Ando, J. Chiba, S. Harada, I. Saito, and T. Miyamura. 1995. Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. J. Gen. Virol. 76:53-61.
56. Suzuki, R., T. Suzuki, K. Ishii, Y. Matsuura, and T. Miyamura. 1999. Processing and functions of hepatitis C virus proteins. Intervirology 42:145-152.
57. Suzuki, R., K. Tamura, J. Li, K. Ishii, Y. Matsuura, T. Miyamura, and T. Suzuki. 2001. Ubiquitin-mediated degradation of hepatitis C virus core protein is regulated by processing at its carboxyl terminus. Virology 280:301-309.
58. Takamizawa, A., C. Mori, I. Fuke, S. Manabe, S. Murakami, J. Fujita, E. Onishi, T. Andoh, I. Yoshida, and H. Okayama. 1991. Structure and organization of the hepatitis C virus genome isolated from human carriers. J. Virol. 65:1105-1113.
59. Tanahashi, N., Y. Murakami, Y. Minami, N. Shimbara, K, B. Hendil, and K. Tanaka. 2000. Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. J. Biol. Chem. 275:14336-14345.
60. Tanahashi, N., K. Yokota, J. Y. Ahn, C. H. Chung, T, Fujiwara, E. Takahashi, G. N. DeMartino, C. A. Slaughter, T. Toyonaga, K, Yamamura, N. Shimbara, and K. Tanaka. 1997. Molecular properties of the proteasome activator PA28 family proteins and gamma-interferon regulation. Genes Cells 2:195-211.
61. Ustrell, V., L. Hoffman, G. Pratt, and M. Rechsteiner. 2002. PA200, a nuclear proteasome activator involved in DNA repair. EMBO J. 21:3516-3525.
62. Wilk, S., W. E. Chen, and R. P. Magnusson. 2000. Properties of the nuclear proteasome activator PA28gamma (REGgamma). Arch. Biochem. Biophys. 383:265-271.
63. Xu, Z., J. Choi, W. Lu, and J. H. Ou. 2003. Hepatitis C virus F protein is a short-lived protein associated with the endoplasmic reticulum. J. Virol. 77:1578-1583.
64. Xu, Z., J. Choi, T. S. Yen, W. Lu, A. Strohecker, S. Govindarajan, D. Chien, M. J. Selby, and J. Ou. 2001. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J. 20:3840-3848.
65. Yasui, K., T. Wakita, K. Tsukiyama-Koharu, S. I. Funahashi, M. Ichikawa, T. Kajita, D. Moradpour, J. R. Wands, and M. Kohara. 1998. The native form and maturation process of hepatitis C virus core protein. J. Virol. 72:6048-6055.
66. Yoshida, T., T. Hanada, T. Tokuhisa, K. Kosai, M. Sata, M. Kohara, and A. Yoshimura. 2002. Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J. Exp. Med. 196:641-653.
67. You, L. R., C. M. Chen, T. S. Yeh, T. Y. Tsai, R. T. Mai, C. H. Lin, and Y. H. Lee. 1999. Hepatitis C virus core protein interacts with cellular putative RNA helicase. J. Virol. 73:2841-28453.
68. Zhang, J., O. Yamada, H. Yoshida, T. Iwai, and H. Araki. 2002. Autogenous translational inhibition of core protein: implication for switch from translation to RNA replication in hepatitis C virus. Virology 293:141-150.
69. Zhang, Z., N. Torii, A. Furusaka, N. Malayaman, Z. Hu, and T. J. Liang. 2000. Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex. J. Biol. Chem. 275:15157-15165.